Pharmaceutical
- Pharmaceutical intermediates
- Heterocyclic Compound
- OLED material intermediate
- Diphenylamine intermediates
- Nutritional Supplements
- Pharmaceutical raw materials
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Urinary System Drugs
- Endocrine System
- Other
Medicine Excipients
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Raw Materials powder Tranexamic acid on sale
Product Overview:
Tranexamic acid has recently attracted wide attention because it was added to Yunnan Baiyao toothpaste. This drug is a good drug widely used in clinical practice. Its important role is to stop bleeding, and it is even considered as a miracle drug for bleeding, mainly used for bleeding after major surgery and postpartum. Of course, hemostasis is probably the least reason for many toothpaste additions to hope to work. The discovery of tranexamic acid is legendary. In the 1950s, Japanese pharmacologist Akiko Okamoto discovered Tranexamicacid (also known as tranexamic acid) while searching for a hemostyptic (it is a well-known whitening product in the beauty industry).
Raw Materials powder Tranexamic acid on sale Attributes
CAS:1197-18-8
MF:C8H15NO2
MW:157.21
EINECS:214-818-2
Specification: 99% min Tranexamic acid powder
Sample:Tranexamic acid powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance:white
Shelf Life: 2 Years
Test Method: HPLC
Raw Materials powder Tranexamic acid on sale Details
Tranexamic acid Powder Usage and Synthesis.
Tranexamic acid, a synthetic derivative of lysine, is a commonly used hemostatic agent in clinical practice. It plays a hemostatic effect by inhibiting the dissolution of fibrin. Tranaminocyclic acid can strongly adsorb lysine-binding sites (LBS) of fibrin affinity sites on plasminase and plasminogen, and inhibit the binding of plasminogen and fibrin, thus strongly inhibiting the fibrin decomposition caused by plasminogen. In addition, the anti-fibrinolytic effect of tranatemic acid was more obvious in the presence of anti-fibrinolytic enzymes such as macroglobulin in serum. It has a bioavailability of 34% and a half-life of 3.1h.
Uses of Tranexamic acid powder.
Tranexamic acid, a synthetic derivative of lysine, is an antifibrinolytic drug with hemostatic properties. Tranaminocyclic acid can strongly adsorb lysine-binding sites (LBS) of fibrin affinity sites on plasminase and plasminogen, and inhibit the binding of plasminogen and fibrin, thus strongly inhibiting the fibrin decomposition caused by plasminogen. In addition, the anti-fibrinolytic effect of tranatemic acid was more obvious in the presence of anti-fibrinolytic enzymes such as macroglobulin in serum. It has a bioavailability of 34% and a half-life of 3.1h.
Pharmacological action of Tranexamic acid.
Tranexamic acid, also known as tranexamic acid, chemical name 4-aminomethyl cyclohexanocarboxylic acid, trade name tosemin. tranexamicacid (tranexamicacid) is a synthetic amino acid anti-fibrinolytic drug, which can competitively inhibit the binding of fibrin lysine and fibrinolytic enzyme, thus inhibiting the cleavage of fibrin clots and producing hemostatic effect. It is mainly used for various bleeding caused by hyperfibrinolysis. Tranatemocyclic acid is a synthetic lysine analogue, which can competitively bind the lysine binding sites on plasminogen and plasminase, thereby competitively inhibiting fibrin degradation, reducing fibrinolytic activity, and promoting coagulation. Theoretically, the use of tranexamic acid may lead to insufficient fibrinolytic activity, which may increase the risk of postoperative thrombotic events.
Product Method of Bulk Tranexamic acid Powder.
